(2) Hepatocyte steatosis occurs in patients infected with the HCV virus, resulting in metabolic disorders of related cytokines (such as a significant increase in visfatin levels) and accelerating the development of HCC (43). This evidence concerns the gene NAMPT and hepatocellular carcinoma.